Výnos na zamestnanca spoločnosti Amgen

Výnos na zamestnanca spoločností v sektore Health Care sektor na XETRA v porovnaní so spoločnosťou Amgen

Čomu sa venuje spoločnosť Amgen?

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and a strategic research and development collaboration with Neumora Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Firmy s metrikou výnos na zamestnanca podobnou spoločnosti Amgen

• Hodnota metriky Výnos na zamestnanca spoločnosti KB Recycling Industries Ltd je $59.850k
• Hodnota metriky Výnos na zamestnanca spoločnosti Theranexus SA je €59.889k
• Hodnota metriky Výnos na zamestnanca spoločnosti Avivagen je CAD$59.923k
• Hodnota metriky Výnos na zamestnanca spoločnosti Sporting Clube de Braga - Futebol, SAD je €59.933k
• Hodnota metriky Výnos na zamestnanca spoločnosti EXMAR NV je $59.960k
• Hodnota metriky Výnos na zamestnanca spoločnosti Idsud S.A je €60.000k
• Hodnota metriky Výnos na zamestnanca spoločnosti Amgen je $60.018k
• Hodnota metriky Výnos na zamestnanca spoločnosti Mitchells & Butlers Plc je £60.364k
• Hodnota metriky Výnos na zamestnanca spoločnosti Alveen S.A je €60.369k
• Hodnota metriky Výnos na zamestnanca spoločnosti Victoria Oil & Gas Plc je $60.438k
• Hodnota metriky Výnos na zamestnanca spoločnosti Almonty Industries je CAD$60.495k
• Hodnota metriky Výnos na zamestnanca spoločnosti Majesco je $60.524k
• Hodnota metriky Výnos na zamestnanca spoločnosti Majesco je $60.524k